Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by SizzlinSteakson Nov 24, 2017 9:16am
103 Views
Post# 27024633

RE:RE:RE:Roger did not give me any insider info

RE:RE:RE:Roger did not give me any insider infoYes, very impressive how far they can stretch out their cash. That being said I also inquired with Roger regarding government funding or all the billions being donated to cancer research on an annual basis. He said they have benefitted from that in the past (I think in conjunction with their partnership with PMH) but unfortunately they don't give handouts to private companies. PMH and American Cancer Society primarily utilize these funds for acedemics. Perhaps this is part of the reason they are able to stretch out their funds for so long but unfortunately no hand outs.

Guisep67 wrote: The science continues to prove itself over and over but the uncertainty over financing is keeping the Sp at the level IMO.

The recent sell off has this factored in. I'm very confident in the management moving forward with more options and leverage whatever the outcome, JV or PP. After all look how far we've progressed to date on a shoestring budget. Amazing.

Good luck longs. Schones wockenende.

Guisep


Bullboard Posts